SA
IBRX logo
ImmunityBio, Inc.(IBRX)
Closing price · checked 8:27 PM ETAbout this dataData status
$6.02▼-0.55 (-8.37%)
Extended:$6.08+0.06 (+1.08%)· 8:27 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Immunitybio Inc (IBRX)

Net Income

-$1.11B

TTM · Period ending: · USD

IBRX logo

IBRX Net Income

Latest reported-$1.11B
IBRX Net Income (-$2.05M → -$1.11B)
Powered by
High-resolution chart · PNG

What is net income?

Net income is the profit or loss remaining after expenses, interest and income taxes.

Compare net income

IBRX net income history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Immunitybio Inc Net Income — Annual fiscal periods (USD)
Period endingNet Income (USD)Change
-351,398,000—
-413,564,000—
-583,196,000—
-416,567,000—
-346,790,000—
-221,851,000—
-65,789,000—
-96,226,000—
-96,423,000—
-120,809,000—
-236,876,000—
-6,213,000—
-2,047,000—

Frequently asked questions: IBRX net income

What is Immunitybio Inc (IBRX)'s current net income?

Immunitybio Inc (IBRX)'s latest reported net income (TTM) is -$1.11B as of Sep 30, 2026. Net income is the profit or loss remaining after expenses, interest and income taxes.

How much historical net income data is available for IBRX?

Stock Alarm Pro provides 13 dated annual fiscal periods observations for Immunitybio Inc (IBRX)'s net income, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare IBRX's net income to peers or set an alert?

You can compare IBRX's net income directly against sector peers (GH, BBIO, GKOS, BTSG) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on IBRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.